Workflow
duit Pharmaceuticals (CDT)
icon
Search documents
CDT Environmental Technology Investment Holdings Limited Files Annual Report on Form 20-F
globenewswire.com· 2024-05-21 00:00
Announced three new patents that feature new AI-powered intelligent waste-sorting technologies Subsequent to 2023 year-end: "Following our IPO just a few weeks ago, we are pleased to report our third consecutive year of growth at both the top- and bottom-lines, with fundamentals continuing to trend well for our shareholders," remarked Yunwu Li, Chief Executive Officer of CDT. "The market demand continues to support the growth of our business, and indeed, we are proud of the consistent progress we have made ...
duit Pharmaceuticals (CDT) - 2024 Q1 - Quarterly Report
2024-05-14 20:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the quarterly period ended March 31, 2024 For the transition period from to | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------| | Delaware \n(State or other jurisdiction of incorporation or organization) \n4995 Murphy Canyon Road, Suit ...
duit Pharmaceuticals (CDT) - 2023 Q4 - Annual Report
2024-04-16 21:29
We currently operate as a virtual company, but also lease property in the United Kingdom. On March 7, 2024, we entered into a lease for laboratory space at Cambridge Science Park. Rent is £92,925 per annum, the equivalent of approximately $10,000 per month. The lease runs until January of 2027, and the laboratory space is intended to provide us with the ability to extend or develop proprietary solid-form intellectual property for existing and future clinical assets Item 4. Mine Safety Disclosures Item 5. Ma ...
Will There Be a TikTok Ban? When, Why and What You Should Know.
InvestorPlace· 2024-04-02 21:53
The U.S. House of Representatives passed a bill on March 13 that stated a requirement for ByteDance, a reputable Chinese tech company, to ban TikTok in the United States. The legislation, now known as the Protecting Americans from Foreign Adversary Controlled Application Act, was forwarded by the U.S. government Reps. Mike Gallagher (R-WI) and Raja Krishnamoorthi (D-IL) on March 5.On March 7, the legislation garnered approval from the Energy and Commerce Committee, as it has been concerned over TikTok’s con ...
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
Newsfilter· 2024-03-19 11:00
Conduit also appoints prominent intellectual property attorney Jeffrey Lindeman as a Consultant Leadership additions underscore Conduit's commitment to strengthening and broadening its intellectual property portfolio through solid-form technology to maximize future value SAN DIEGO and LONDON, March 19, 2024 (GLOBE NEWSWIRE) --  Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit Pharmaceuticals" or "Conduit" or the "Company") today announced the appointment of Dr. Joanne Holland as Chief Scientific Officer. ...
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub
Newsfilter· 2024-03-11 11:00
SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation. This strategic acquisition marks a pivotal milestone for Conduit, positioning the Company for portfolio expansion, enhanced development capabilities, and growth of a robust inte ...
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Newsfilter· 2024-01-31 13:30
SAN DIEGO and LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit"), a multi-asset, clinical-stage life science company delivering an efficient model for compound development, today announced CEO Dr. David Tapolczay, will be participating in the Oppenheimer 34th Annual Healthcare Life Sciences Conference, being held February 13-14, 2024. Dr. Tapolczay is scheduled to present on Wednesday, February 14, 2024, at 8:00 am EST/13:30 GMT, and will be participating in one- ...
duit Pharmaceuticals (CDT) - 2023 Q3 - Quarterly Report
2023-11-19 16:00
| --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------|-------|---------------------------|-------|--------------------| | Net cash (used in) provided by: \nOperating Activities | $ | Months 2023 \n(2,922) | \n$ | 30, 2022 \n(1,386) | | Investing Activities | | 228 | | (129) | | Financing Activities | | 11,343 | | 1,515 | | Effect of exchange rate changes on cash and cash equivalents | | (5) | | - | | Net (decrease) increase in cash and cash equival ...
duit Pharmaceuticals (CDT) - 2023 Q2 - Quarterly Report
2023-08-13 16:00
As of the date of this Quarterly Report on Form 10-Q, there have been no material changes from the risk factors previously disclosed in our Annual Report for the year ended December 31, 2022, except as set forth below. Risks associated with the Merger and Conduit are more fully discussed in the Form S-4 that the Company has filed, as may be amended. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not p ...
duit Pharmaceuticals (CDT) - 2023 Q1 - Quarterly Report
2023-05-14 16:00
● increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; Merger Agreement In connection with the transactions contemplated by the Merger Agreement, we entered into a subscription agreement (the "Subscription Agreement") with an investor. Pursuant to the Subscription Agreement, the investor has agreed to purchase $27 million (the "Private Placement") units of our securities, with each unit consisting of (i) one share o ...